Product Information
KETODAN 2% FOAM is a generic product labeled by Medimetriks Pharmaceuticals Inc., priced at $3.4406 per GM under NDC 43538053010. Its NADAC has been published 131 times since Nov 28, 2013.
FDA first approved this application on Aug 25, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ketoconazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/g
Manufacturer
Medimetriks Pharmaceuticals Inc.NDC
43538053010
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
KETOCONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA091550FDA Approved
8/25/2011
TE Code
AB
On Market Since
6/15/2012
Pharmacological Classes
Price Statistics
The NADAC for KETODAN 2% FOAM has been published 131 times since Nov 28, 2013, and over the history we have for it it has risen 19.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4406 per GM |
|---|---|
| All-time high | $3.8345 (Nov 13, 2024) |
| All-time low | $2.3325 (Jan 21, 2026) |
| 52-week high | $3.4406 |
| 52-week low | $2.3325 |
| Median price | $3.0424 |
| Average price | $3.0677 |
| Largest weekly change | +26.8% (Jul 17, 2024) |
| Weeks tracked | 131 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ketoconazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medimetriks Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ketoconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETODAN 2% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for KETODAN 2% FOAM, manufactured by Medimetriks Pharmaceuticals Inc., is $3.4406 per GM (NDC 43538053010), effective Sep 30, 2026.
How has the price of KETODAN 2% FOAM changed over time?
Over the history we have for it, the NADAC for KETODAN 2% FOAM has risen 19.3%. It has been tracked across 131 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETODAN 2% FOAM?
Since Nov 28, 2013, the NADAC for KETODAN 2% FOAM has ranged from a low of $2.3325 (Jan 21, 2026) to a high of $3.8345 (Nov 13, 2024), with a median of $3.0424 per GM.
Are there cheaper alternatives to KETODAN 2% FOAM?
No other NADAC-published product currently shares the active ingredient and strength of KETODAN 2% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KETODAN 2% FOAM?
KETODAN 2% FOAM (NDC 43538053010) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a generic product.